Society for Clinical Trials 37th Annual Meeting 2016

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Tips to a Successful Monitoring Visit
Quality Management within the Clinical Research Process
A Blueprint For Clinical Research: Standard Operating Procedures
2013 CTN Web Seminar Series Produced by: NIDA CTN CCC Training Office "This training has been funded in whole or in part with Federal funds from the National.
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
Personnel. 2 Purchasing & Inventory Assessment Occurrence Management Information Management Process Improvement Customer Service Facilities & Safety The.
I’m Not Even Sure What Questions to Ask (or whom to ask)! A Litany of Queries for New DTCs Presented by Joy Harris Philpott San Marcos CISD Tenth Annual.
M ODULE H I NTERIM M ONITORING V ISIT Denise Thwing 21 Apr Version: Final 21-Apr-2010.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
STUDY CLOSE OUT KEMRI-Wellcome Trust Research Programme Version: 4-Nov-2008.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
T16 Phase I studies – Phase I units and you, a Phase I unit’s expectation – A Day in the Life of a Phase I Study Coordinator Jeffery Wong, Clinical Research.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Introduction to the new SHC Health Information Record Manual Presented by Rhonda Anderson, RHIA President Anderson Health Information Systems, Inc
Research Studies GOTCHA’S By Sally Duffy. Failure to follow protocol, investigator agreements and regulations Did not use device/drug in manner specified.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
1 Thank you for visiting our site and welcome to the “Introduction to ISO 22000” Presentation that you requested. For more information.
Monitoring the Progress of Clinical Trials in a Network Setting: Experience from the National Drug Abuse Treatment Clinical Trials Network P. VanVeldhuisen.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Study Closure Process Entropy is not a method Rachel Sheppard Regulatory Director, OCRSS.
Systems Accreditation Berkeley County School District School Facilitator Training October 7, 2014 Dr. Rodney Thompson Superintendent.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Sponsor Visits and Monitoring
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Surviving CTIMPs and MHRA inspections Kim Gooding Diabetes and Vascular Medicine UEMS and Exeter CRF Exeter Clinical Research Facility.
Guidance for Researchers on Using the Wisconsin IRB Consortium (WIC) February 2014.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
New Employee Orientation
Remote Site Initiation Visits
Design of Case Report Forms
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
The Role and Responsibilities of the Clinical Research Coordinator
Responsibilities of Sponsor, Investigator and Monitor
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S SITE FILE
Investigator of Record – Definition
Best practices for study drug management and accountability throughout the study lifecycle in multi-site randomized controlled trials Dikla Shmueli-Blumberg.
What is a Data and Safety Monitoring Plan and how do I get one?
Community Participation in Research
New Coordinator CRU Orientation
Remote Monitoring of Adverse Events
Jennifer S. Novia INFO 643 March 6, 2011
Training for New District Test Coordinators
Remote Monitoring of Protocol Deviations
NHLBI Perspective Yves Rosenberg, M.D, M.P.H.
Remote Monitoring of Adverse Events
Project Based Research
ARCADIA Coordinator Webinar
SERIOUS ADVERSE EVENTS REPORTING
Myeloma UK Clinical Trial Network (CTN)
RECORDS AND INFORMATION
Investigator of Record – Definition
Investigator of Record – Definition
Society for Clinical Trials, 37th Annual Meeting
Sponsor-Investigator (SI) FDA Inspections
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Data Management in Support of A Clinical Event Committee (CEC)
Leveraging online technology for purposes of remote monitoring throughout the protocol lifecycle Dee Blumberg, Donna Brown, Ashley Case, Kayla Daniels,
Preparing for Short-term Campus Closures
Understanding the Process of Documenting Informed Consent
CTSA27 So you want COMIRB to be your sIRB: What you need to know.
Presentation transcript:

Society for Clinical Trials 37th Annual Meeting 2016 Study Cl se ut Society for Clinical Trials 37th Annual Meeting 2016 Developing a Comprehensive and Effective Process for Closing Out a Study: Strategies From Closing Out Multi-Site Substance Use Treatment Clinical Trials Introduction of myself, maybe ask if anyone has ever participated in a close out of a study? Dee Blumberg, Donna Brown, Kayla Daniels, Denise King, Beth Jeffries The NIDA CTN Clinical Coordinating Center at The Emmes Corporation - May 18, 2016

Study Close Out Preparation Scheduling Managing study close out: Safety & regulatory Data cleaning Storage & record retention Study personnel Medication & supplies Follow up

Study Close Out Preparation for an efficient close out begins before the study starts Careful and timely execution of all trial-related duties throughout the implementation phase will aid the close out process Study closeout activities are performed to confirm that the site investigator’s study obligations have been met and post study obligations are understood. Closeout activities verify that study procedures have been completed, data collected, and if relevant, study intervention is returned to the responsible party or prepared for destruction. Begin early- should incorporate in MOP …

National Drug Abuse Treatment Clinical Trials Network Multi-center Trials Multisite trials Research sites in the U.S. and Canada Clinical Coordinating Center (CCC) at Emmes Central Regulatory document collection Central QA, Safety, and Medical monitoring Site activation, monitoring throughout the study and close out From our abstract: The close out phase is an extremely important component of any clinical trial, and requires forethought and careful planning in order to be successful and efficient. This process may be particularly complex with multi-site trials, where an additional layer of coordination is necessary. For over 10 years the National Institute on Drug Abuse (NIDA) Clinical Coordinating Center (CCC) has supported the National Drug Abuse Treatment Clinical Trials Network (CTN) which test substance use treatment interventions in multi-site clinical trials. Throughout that time, the CCC has developed best practices for a methodical, cost-effective and successful study close out process.

Preparing for Study Close Out Strategies for Efficient Close Out Close Out Readiness Checklist Comprehensive Detailed Clear Provided far in advance of close out Close Out Readiness site calls- assess the site’s status and progress with close out tasks Strategies: Do whatever you can remotely (sometimes entire SV will be remote…) Provide tools to help sites prepare- e.g., calls, checklist… Keep everyone in the loop- monitors… An interdisciplinary team within the CCC and Data and Statistics Center (DSC) work closely together to monitor and guide the sites with their regulatory, safety, data, supply, and medication related assignments in order to ensure that close out is accomplished in an organized and timely manner.

CTN Site Close Out Checklist Strategies: Do whatever you can remotely (sometimes entire SV will be remote…) Provide tools to help sites prepare- e.g., calls, checklist… Keep everyone in the loop- monitors… An interdisciplinary team within the CCC and Data and Statistics Center (DSC) work closely together to monitor and guide the sites with their regulatory, safety, data, supply, and medication related assignments in order to ensure that close out is accomplished in an organized and timely manner.

CTN Site Close Out Checklist Detailed- rather than saying “make sure all your reg docs are in the binder” we provide very specific list of what we expect. Clarity- for each item we clarify the method of submission, whether it has been submitted to RTS and placed in binder, and whether and when that has been verified….

Scheduling Study Close Out Monitoring site progress via the close out readiness checklist and readiness calls assists with scheduling the Close Out Visit at the right time Many tasks can be performed and confirmed remotely in advance of the visit (e.g., collection of regulatory documents) The study monitor will schedule the visit (give several options) and specify which site staff must be present

Components of Site Close Out Monitoring Visits Study Personnel Medication, Supplies & Equipment Safety & Regulatory Data Cleaning Storage & Record Retention When I talk about these go clockwise… For storage say important to have contact person. Add some wording on each that gives some info, like storage and record retention LOCATION, medication supplies DISPOSITION… An interdisciplinary team within the CCC and Data and Statistics Center (DSC) work closely together to monitor and guide the sites with their regulatory, safety, data, supply, and medication related assignments in order to ensure that close out is accomplished in an organized and timely manner. All outstanding Case Report Forms (CRFs) have been corrected, collected, organized, and filed as required. All data queries are corrected and resolved All serious adverse events (SAEs) have been reported to the DSMB (or Safety Monitor), sponsor, Institutional Review Board (IRB), and other organizations, as specified in the protocol. All adverse events and serious adverse events (SAEs) are recorded and followed up to resolution in accordance with procedure detailed in the protocol. Campanella, M. (2013). CTN Webinar: Site closeout – An overview. Retrieved from http://ctndisseminationlibrary.org/display/974.htm.

Following Up After Study Close Out Report distributed with outstanding issues and pertinent findings Action item memo distributed – indicating completion A regulatory report is attached - A study close out visit report is sent including site status, any outstanding issues and pertinent findings - The CCC staff follows up on all action items and ultimately issues a memo that acknowledges that all action items identified during close out visit have been completed - A report is attached to the memo, summarizing the list of regulatory documents that are on file at the CCC

Lessons Learned Start thinking about and preparing early in study, checklist should be prepared in advance We’ve done trainings on close out before happens to tell them what to expect, reduce confusion and anxiety Incorporate steakholders- close out is a collabortive process, calls and checklist should reflect this too- all should input… Have all info in same place- checklist should be inclusive…

Thank You! Questions/Comments? For more information contact: Dee Blumberg Project Manager, Clinical Coordinating Center National Drug Abuse Treatment Clinical Trials Network The Emmes Corporation 401 N. Washington Street, 7th Floor Rockville, MD  20850 Phone: 301-251-1161 ext 2867 Fax: 301-576-3924 Email: dblumberg@emmes.com Thank You! At some point in slides need to talk about site staff leaving, checklist helps them get stuff done before everyone is off, and also sites should understand expectations so know who needs to stay (e.g., someone that can handle data queries…)